PAGS (PagSeguro Digital) 2026 stock outlook. A deep qualitative look at Brazil merchant acquiring and TPV growth, the PagBank digital banking deposit engine, the four-way fight with Nubank, StoneCo and Mercado Pago, Selic rate and real FX macro, and what it all means for a US investor.
A practical 2026 guide to the conservation easement charitable income-tax deduction: how a qualified conservation contribution works, the appraisal and perpetuity rules, AGI deduction limits and carryforwards, and how the IRS separates a legitimate land donation from an abusive syndicated easement that triggers disallowance and steep penalties.
IRTC (iRhythm Technologies) stock outlook for 2026. A deep, qualitative look at the Zio long-term ECG patch and AI arrhythmia analysis, ambulatory-monitoring standardization, Medicare reimbursement risk, competition from Boston Scientific, and the path to durable profitability.
NARI (Inari Medical) 2026 stock outlook. A deep qualitative look at the FlowTriever and ClotTriever mechanical thrombectomy franchise, the venous thromboembolism (VTE) TAM and penetration story, competition from Penumbra and Boston Scientific, reimbursement dynamics, and what Stryker's strategic interest means for investors.
How a U.S. private annuity sale lets you transfer an appreciated business, real estate, or stock to a family member or trust in exchange for a lifetime annuity, freezing your taxable estate and spreading gain, plus the §7520 rate, mortality risk, IRS scrutiny, and how it compares to an installment sale and a SCIN.
A plain-English guide to U.S. defective medical device lawsuits — hip and knee implants, hernia mesh, IVC filters, CPAP, breast implants, insulin pumps. Understand 510(k) vs. PMA and the preemption defense, MDL vs. class action, how settlement ranges actually form, the statute of limitations, and how to choose a contingency-fee lawyer.
Primoris Services (NYSE: PRIM) 2026 stock outlook. A deep look at its utilities and energy segments, solar EPC and power-delivery construction, the data-center-driven grid capex supercycle, backlog quality, fixed-price cost risk, execution, cyclicality, and how PRIM stacks up against PWR, MTZ, EME, and STRL.
A working electrician's guide to business insurance costs in 2026 — general liability, workers' comp class codes, commercial auto, tools and equipment, professional liability, and umbrella coverage, with realistic premium ranges, the drivers that move your rate, ways to save, and the mistakes that leave contractors exposed.
ESNT (Essent Group) 2026 stock outlook. A qualitative deep dive into the private mortgage insurance (PMI) business model, insurance-in-force, persistency, defaults and PMIERs capital, the low-LTV credit cycle, housing and rate risks, capital return, and how Essent stacks up against MTG, RDN, ACT and NMIH for long-term investors.
A practical 2026 guide to HVAC contractor business insurance cost in the US: the full coverage stack — general liability, workers' comp HVAC class codes, commercial auto, tools and equipment, inland marine, umbrella — plus premium drivers, typical annual cost ranges, ways to lower your premium, and the mistakes that get claims denied.
StepStone Group (NASDAQ: STEP) 2026 stock outlook. A deep qualitative look at the private-markets solutions model, fund-of-funds, secondaries and co-investments, discretionary AUM versus advisory assets, fee-related earnings visibility against carried-interest volatility, the private-wealth push, and how STEP stacks up against BX, KKR, APO, ARES and OWL.
CVCO (Cavco Industries) 2026 stock outlook. A deep qualitative look at manufactured and modular housing riding the US affordability crisis, the build-finance-insure vertical model, chattel-loan rate sensitivity, the Skyline Champion and Clayton rivalry, and what investors should watch each quarter.
Integer Holdings (NYSE: ITGR) 2026 stock outlook. A deep, qualitative look at the medical-device contract design and manufacturing model, the cardio and vascular growth mix, the bolt-on M&A roll-up strategy, margin leverage, and the customer-concentration and leverage risks every ITGR investor should weigh.
Powell Industries (NASDAQ: POWL) stock outlook for 2026. A deep, qualitative look at its custom medium-voltage switchgear and integrated power modules (E-Houses), the data-center, grid and LNG capex tailwinds, record backlog, project-cycle and margin-normalization risks, plus how to think about position sizing for US investors.
Nibec (138610) 2026 stock outlook. A deep, qualitative look at the KOSDAQ peptide platform company's cell-penetrating drug-delivery and tissue-regeneration technology, its cash-generating bone-graft and dental biomaterials, the out-licensing upside, and the clinical and cash-burn risks foreign investors should weigh.
Ray Co (228670) 2026 stock outlook. A deep qualitative look at the KOSDAQ digital-dentistry maker of dental CBCT imaging, intraoral scanners and dental 3D printing, its ex-Samsung imaging lineage, global dental DX tailwind, export and FX cycles, and what a foreign investor should weigh before buying a small-cap Korean med-tech name.
Haatz (111110) 2026 stock outlook. A deep, qualitative look at the Korean kitchen range hood and home ventilation leader — its vendor-relationship moat, built-in versus remodeling demand, the indoor-air-quality growth vector, housing-cycle risk, and what a foreign investor should know about KRW exposure and Korean dividend withholding.
Dongwon Development (013120) 2026 stock outlook. A deep, qualitative look at the Busan-Gyeongnam housing developer's near debt-free balance sheet, its build-and-sell (developer plus contractor) model, dividend appeal, real-estate PF risk, and exposure to regional pre-sale cycles for a foreign investor buying a Korean equity.
Chemtros (220260) 2026 stock outlook. A deep qualitative look at this KOSDAQ specialty-chemicals maker: semiconductor and display electronic materials, UV-curable resins, functional additives, the spec-in moat behind materials localization, and the customer-concentration, cyclicality, and small-cap liquidity risks a foreign investor buying a Korean equity should weigh.
Taekwang (023160) 2026 stock outlook. A deep qualitative look at the forged pipe-fittings business for shipbuilding, plant and petrochemical, leverage to the LNG carrier and energy capex cycle, order backlog, the Sungkwang Bend rivalry, and what a foreign investor should know about buying this Korean equity. Not to be confused with Taekwang Industrial (003240).
MS Autotech (123040) 2026 stock outlook. A deep, qualitative read on hot-stamped high-tensile automotive body parts, the Myungshin group's vertical integration, Myungshin Industries' Tesla supply, the Hyundai-Kia dual-customer base, EV lightweighting tailwinds, and the volume, FX, and pricing risks a foreign investor faces buying this Korean small-cap.
TSI (277880) stock outlook for 2026. A deep, qualitative look at this KOSDAQ maker of secondary-battery slurry mixing systems: the business model and moat, how revenue tracks global cell-maker capex, the concentration and cycle risks, its position among Korean battery-equipment peers, and what a foreign investor should watch each quarter.
YAS 255440 stock outlook 2026: large-area OLED evaporation deposition equipment localization, Samsung Display 8.6G IT OLED capex leverage, order lumpiness and single-customer concentration risk, plus a foreign investor's guide to KRX access, KRW/USD FX, Korean dividend withholding, and bull/base/bear scenarios.
RaonTech (232680) 2026 stock outlook. A deep qualitative look at the KOSDAQ fabless designer of OLEDoS and LEDoS microdisplays for AR/VR headsets, its Samsung and Meta supply-chain optionality, XR adoption leverage, loss-making risk, Sony and Kopin competition, and the tax picture for foreign investors buying a Korean equity.